Fitness and molecular mechanisms of resistance to rifaximin in in vitro selected Escherichia coli mutants

Microbial Drug Resistance

Volumn 18, Issue 4, 2012, Pages 376-379

  Pons, Maria J ^a   Mensa, Laura ^a   Gascón, Joaquim ^a   Ruiz, Joaquim ^a  

^a INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CARRIER PROTEIN; RIFAXIMIN; RNA POLYMERASE BETA SUBUNIT;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM ISOLATE; BACTERIUM MUTANT; ESCHERICHIA COLI; GENE MUTATION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RPOB GENE;

ANTI-BACTERIAL AGENTS; BACTERIAL OUTER MEMBRANE PROTEINS; DIPEPTIDES; DRUG RESISTANCE, BACTERIAL; ESCHERICHIA COLI; ESCHERICHIA COLI PROTEINS; GENE EXPRESSION REGULATION, BACTERIAL; HUMANS; MICROBIAL SENSITIVITY TESTS; POINT MUTATION; RIFAMYCINS;

ESCHERICHIA COLI;

EID: 84864349999     PISSN: 10766294     EISSN: 19318448     Source Type: Journal    
DOI: 10.1089/mdr.2011.0010     Document Type: Article

References (16)

1. Baysarowich, J., K. Koteva, D. Hughes, L. Ejim, E. Griffiths, K. Zhang, M. Junop, and G.D. Wright. 2008. Rifamycin antibiotic resistance by ADP-ribosylation structure and diversity of Arr. Proc. Natl. Acad. Sci. 105:4886-4891.
2. Bryce, J., C. Boschi-Pinto, K. Shibuya, and R.E. Black. 2005. WHO estimates of the causes of death in children. Lancet 365:1147-1152.
3. Gascó n, J. 2006. Epidemiology, etiology and pathophysiology of traveler's diarrhea. Digestion 73 Suppl 1:102-108.
4. Hart, C.A., and S. Kariuki. 1998. Antimicrobial resistance in developing countries. BMJ 317:647-650.
5. Huang, D., and H.L. Dupont. 2005. Rifaximin-a novel antimicrobial for enteric infections. J. Infect. 50:97-106.
6. Layer, P., and V. Andresen. 2010. Review article: Rifaximin, a minimally absorbed oral antibacterial, for the treatment of traveller's diarrhoea. Aliment. Pharmacol. Ther. 31:1155-1164.
7. Mensa, L., F. Marco, J. Vila, and J. Ruiz. 2008. Quinolone resistance among Shigella spp. isolated from travellers returning from India. Clin. Microbiol. Infect. 14:279-281.
8. Ruiz, J., F. Marco, I. Oliveira, J. Vila, and J. Gascó n. 2007. Trends in antimicrobial resistance in Campylobacter spp. causing traveller's diarrhea. APMIS 115:218-224.
9. Ruiz, J., L. Mensa, C. O'Callaghan, M.J. Pons, A. Gonzalez, J. Vila, and J. Gascó n. 2007. In vitro antimicrobial activity of rifaximin against enteropathogens causing traveller's diarrhea. Diagn. Microbiol. Infect. Dis. 59:473-475.
10. Ruiz, J., L. Mensa, M.J. Pons, J. Vila, and J. Gascó n. 2008. Development of Escherichia coli rifaximin-resistant mutants: Frequency of selection and stability. J. Antimicrob. Chemother. 61:1016-1019.
11. Sáenz, Y., J. Ruiz, M. Zarazaga, M. Teixidó , C. Torres, and J. Vila. 2002. Effect of efflux pump inhibitor Phe-Arg-bnaphthylamide on the MIC values of the quinolones, tetracycline and chloramphenicol, in Escherichia coli isolates of different origin. J. Antimicrob. Chemother. 53:544-545.
12. Scarpignato, C., and I. Pelosini. 2005. Rifaximin, a poorly absorbed antibiotic: Pharmacology and clinical potential. Chemotherapy 51:36-38.
13. Severinov, K., M. Soushko, A. Goldfarbs, and V. Nikiforov. 1993. New rifampicin-resistant and streptolydigin- resistant mutants in the b subunit of Escherichia coli RNA polymerase. J. Biol. Chem. 268:14820-14825.
14. Tavío, M., J. Vila, M. Perilli, L. Casañ as, L. Maciá, G. Amicosante, and M.T. Jiménez de Anta. 2004. Enhanced active efflux, repression of porin synthesis and development of Mar phenotype by diazepam in two enterobacteria strains. J. Med. Microb. 53:1119-1122.
15. Tupin, A., M. Gualtieri, F. Roquet-Banères, Z. Morichaud, K. Brodolin, and J.P. Leonetti. 2010. Resistance to rifampicin: At the crossroads between ecological, genomic and medical concerns. Int. J. Antimicrob. Agents 35:519-523.
16. Xu, M., Y. Ning, B.P. Goldstein, and D.J. Jin. 2005. Crossresistance of Escherichia coli RNA polymerases confering rifampin resistance to different antibiotics. J. Bacteriol. 187:2783-2792.